Execs On The Move: Slew Of Firms Hire Finance Chiefs; New Directors Join Medtech Boards
New CFOs have joined medtech firms such as AdaptHealth, Alydia Health and IQVIA; COVID-19 diagnostic company Privapath Diagnostics has a new president; more than a dozen companies have hired new directors to their board; and more.
You may also be interested in...
Illumina announced on 21 September it will buy back Grail, which is planning to commercialize its multi-cancer early detection blood test Galleri in 2021. See what Illumina’s CEO Francis deSouza said about it here.
Yes, Gottlieb’s in there twice; things get complicated when an agency starts to lose credibility.
Newly published data and results presented at ESMO for Amgen’s sotorasib (AMG 510) show relatively long-lasting responses and progression-free survival in lung cancer.